WELCOME TO The government REPORT
Newsletter | Member Login | Signup
Home > Companies > Ville de Repentigny
Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...
Conference
Webinar
Government Business
Granicus | August 26, 2021
Granicus, the leading provider of cloud-based digital experience solutions for the public sector, today announced the acquisition of GovQA, the nation’s leading provider of public records and compliance workflow solutions for government. With the addition of GovQA, Granicus continues to extend the capabilities of its Civic Engagement Platform, helping government officials deliver consistent, unified digital experiences to their communities while automating, streamlining and ...
Reuters | February 18, 2020
President Donald Trump objected on Tuesday to U.S. proposals that would prevent companies from supplying jet engines and other components to China’s aviation industry and suggested he had instructed his administration not to implement them. In a series of tweets and in comments to reporters on Tuesday, Trump said national security concerns, which had been cited as reasoning for the plans, should not be used as an excuse to make it difficult for foreign countries to buy U.S. products....
Emerging Technology
Relativity | November 10, 2020
Relativity, a worldwide lawful and consistence innovation organization, today reported it has accomplished Federal Risk and Authorization Management Program (FedRAMP) Authority to Operate (ATO) at the Moderate security sway level for its RelativityOne Government administration offering. Relativity accomplished this approval in organization with its supporting office, the Environmental Protection Agency (EPA), achieving ATO for EPA's committed climate as extended on Sept. 14. F...
Merck | December 22, 2021
Merck , known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics today announced that the United Kingdom Government will purchase an additional 1.75 million patient courses of molnupiravir (MK-4482), an investigational oral antiviral COVID-19 medicine. In the U.K., LAGEVRIO® is the planned trademark for molnupiravir; the trademark for molnupiravir in other countries has not been approved. With this additional procurement agreement, which follows a previously announced...
Article
Video
Keep me plugged in with the best
Join thousands of your peers and receive our weekly newsletter with the latest news, industry events, customer insights, and market intelligence.
Welcome back!
Put your news, events, company, and promotional content in front of thousands of your peers and potential customers.
Not a member yet? Not a problem, Sign Up
Sign up
Sign up to contribute and publish your news, events, brand, and content with the community for FREE